Epidemiologically, systematic review and meta-analysis found that BD type 1 has a pooled lifetime prevalence of 1.06% and 1.57% for BD type 2 [10], but numbers keep rising

Major Ingredients Purified Water, Ethylhexyl Palmitate, Glycereth-26, Glycerin, Cetearyl Alcohol, Niacinamide, Hydrogenated Poly(C6-14 Olefin), Beeswax, Caprylic/Capric Triglyceride, Polyglyceryl-2 Stearate, Dipropylene Glycol, Isododecane, Glyceryl Stearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Stearyl Alcohol, Glycol Stearate SE, Sodium Polyacrylate, Hydroxyacetophenone, Stearic Acid, Dimethiconol, Dimethicone/Vinyl Dimethicone Crosspolymer, Hydrogenated Polydecene, Hydrogenated Lecithin, Tranexamic Acid (1,000ppm), Betaine, Glutathione (1,000ppm), Panthenol, Hippophae Rhamnoides Fruit Oil, Butylene Glycol, Adenosine, Sorbitan Isostearate, Caprylyl Glycol, Trideceth-6, 1,2-Hexanediol, Disodium EDTA, Sodium Hyaluronate, Ascorbic Acid Ingredients subject to change at manufacturer's discretion

In contrast, the starting doses of the Wegovy pen (0.25 mg and 0.5 mg), which are administered once weekly, cost about $199 per month for the first two months and increase to up to $349 per month as the dose increases
This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer, senior study author Bernard Fuemmeler, PhD, MPH, of Virginia Commonwealth University Massey Comprehensive Cancer Center said in a news release
J Drugs Dermatol 2013;12(9 Suppl):s123-s127
& Gutmann, H